Biochip Technology Opens Door to Tailoring Chemotherapy
American College of Surgeons (ACS)Researchers from McGill University and other cancer research centers in Canada and the US will begin testing a technology that uses a biochip microarray to tailor chemotherapy to the genetic makeup of a specific malignancy, they reported at the American College of Surgeons Annual Clinical Congress held Oct. 10-15 in San Francisco.